Pei He

558 total citations
24 papers, 374 citations indexed

About

Pei He is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Pei He has authored 24 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Pei He's work include Cancer Immunotherapy and Biomarkers (6 papers), Ferroptosis and cancer prognosis (3 papers) and MicroRNA in disease regulation (3 papers). Pei He is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Ferroptosis and cancer prognosis (3 papers) and MicroRNA in disease regulation (3 papers). Pei He collaborates with scholars based in China, United States and France. Pei He's co-authors include Feng Xu, Haoyu Lin, Yongsong Chen, Jiexin Chen, Ling Lin, Yue Huang, Zhiling Li, Marcus Ballinger, Achim Rittmeyer and Donald P. McManus and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Pei He

23 papers receiving 365 citations

Peers

Pei He
Yuanfa Feng China
A Tschuschner Germany
Saud Azam Saudi Arabia
Ezzat Dadkhah Iran
Yuki Kawai Japan
Magdalena Frydrychowicz Poland
Silvana Russo Italy
Joe Ibrahim Belgium
Xufeng Luo China
Baldeep Wirk United States
Yuanfa Feng China
Pei He
Citations per year, relative to Pei He Pei He (= 1×) peers Yuanfa Feng

Countries citing papers authored by Pei He

Since Specialization
Citations

This map shows the geographic impact of Pei He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pei He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pei He more than expected).

Fields of papers citing papers by Pei He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pei He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pei He. The network helps show where Pei He may publish in the future.

Co-authorship network of co-authors of Pei He

This figure shows the co-authorship network connecting the top 25 collaborators of Pei He. A scholar is included among the top collaborators of Pei He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pei He. Pei He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gan, B.K., Lei Wu, Zhihong Chen, et al.. (2025). Comprehensive analysis of publications concerning combinations of immunotherapy and targeted therapies for hepatocellular carcinoma: a bibliometric study. Frontiers in Immunology. 16. 1476146–1476146. 2 indexed citations
2.
Wu, Shangjie, Xiao Liang, Chen Zhu, et al.. (2024). The role of 4D flow MRI in deep vein thrombosis research. SHILAP Revista de lepidopterología. 3(1). 100123–100123. 1 indexed citations
3.
4.
Li, Zhiling, et al.. (2021). High Dosages of Equine Chorionic Gonadotropin Exert Adverse Effects on the Developmental Competence of IVF-Derived Mouse Embryos and Cause Oxidative Stress-Induced Aneuploidy. Frontiers in Cell and Developmental Biology. 8. 609290–609290. 14 indexed citations
5.
6.
Lu, Liaoxun, et al.. (2020). Loss of natural resistance to schistosome in T cell deficient rat. PLoS neglected tropical diseases. 14(12). e0008909–e0008909. 9 indexed citations
7.
He, Pei, et al.. (2020). AMPK Activity Contributes to G2 Arrest and DNA Damage Decrease via p53/p21 Pathways in Oxidatively Damaged Mouse Zygotes. Frontiers in Cell and Developmental Biology. 8. 539485–539485. 23 indexed citations
8.
Ding, Yang, Pei He, & Zhiling Li. (2020). MicroRNA-9119 regulates cell viability of granulosa cells in polycystic ovarian syndrome via mediating Dicer expression. Molecular and Cellular Biochemistry. 465(1-2). 187–197. 6 indexed citations
9.
Xu, Feng, Haoyu Lin, Pei He, et al.. (2020). A TP53 -associated gene signature for prediction of prognosis and therapeutic responses in lung squamous cell carcinoma. OncoImmunology. 9(1). 1731943–1731943. 85 indexed citations
10.
Han, Ning, Ling Zuo, Han Chen, et al.. (2019). <p>Long non-coding RNA homeobox A11 antisense RNA (HOXA11-AS) promotes retinoblastoma progression via sponging miR-506-3p</p>. OncoTargets and Therapy. Volume 12. 3509–3517. 20 indexed citations
11.
Claret, Laurent, Jin Y. Jin, Charles Ferté, et al.. (2018). A Model of Overall Survival Predicts Treatment Outcomes with Atezolizumab versus Chemotherapy in Non–Small Cell Lung Cancer Based on Early Tumor Kinetics. Clinical Cancer Research. 24(14). 3292–3298. 53 indexed citations
12.
Xie, Xiaolei, et al.. (2018). Repression of Akt3 gene transcription by the tumor suppressor RIZ1. Scientific Reports. 8(1). 1528–1528. 8 indexed citations
13.
He, Pei, Catherine A. Gordon, Gail Williams, et al.. (2018). Real-time PCR diagnosis of Schistosoma japonicum in low transmission areas of China. Infectious Diseases of Poverty. 7(1). 8–8. 42 indexed citations
14.
He, Pei, Xiaoyun Lei, Dejian Yuan, Zuobin Zhu, & Shi Huang. (2017). Accumulation of minor alleles and risk prediction in schizophrenia. Scientific Reports. 7(1). 11661–11661. 12 indexed citations
15.
Gandara, David R., Joachim von Pawel, Åslaug Helland, et al.. (2017). Impact of atezolizumab (atezo) treatment beyond disease progression (TBP) in advanced NSCLC: Results from the randomized phase III OAK study.. Journal of Clinical Oncology. 35(15_suppl). 9001–9001. 14 indexed citations
16.
Claret, Laurent, Jin Y. Jin, Helen Winter, et al.. (2017). Model-based prediction of outcome of the atezolizumab Phase 3 study OAK in non-small cell lung cancer based on early tumor kinetic data.. Journal of Clinical Oncology. 35(15_suppl). e14517–e14517. 2 indexed citations
17.
He, Pei, et al.. (2014). Placental proteome alterations in women with intrahepatic cholestasis of pregnancy. International Journal of Gynecology & Obstetrics. 126(3). 256–259. 13 indexed citations
18.
Xiao, Jie, et al.. (2010). Time course of action and pharmacokinetics of ropivacaine in adult and elderly patients following combined lumbar plexus-sciatic nerve block. International Journal of Clinical Pharmacology and Therapeutics. 48(9). 608–613. 10 indexed citations
19.
He, Pei, et al.. (2009). pcDNA3.1(−)-mediated ribozyme targeting of HER-2 suppresses breast cancer tumor growth. Molecular Biology Reports. 37(3). 1597–1604. 9 indexed citations
20.
He, Pei, et al.. (1999). [Expression of MAGE-1 gene in hepatocellular carcinoma].. PubMed. 7(2). 91–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuanfa Feng Breakdown of academic impact, for papers by A Tschuschner Breakdown of academic impact, for papers by Saud Azam Breakdown of academic impact, for papers by Ezzat Dadkhah Breakdown of academic impact, for papers by Yuki Kawai Breakdown of academic impact, for papers by Magdalena Frydrychowicz Breakdown of academic impact, for papers by Silvana Russo Breakdown of academic impact, for papers by Joe Ibrahim Breakdown of academic impact, for papers by Xufeng Luo Breakdown of academic impact, for papers by Baldeep Wirk
Rankless by CCL
2026